Phase II trial of RXI 109 for treatment of keloids

Trial Profile

Phase II trial of RXI 109 for treatment of keloids

Planning
Phase of Trial: Phase II

Latest Information Update: 25 Mar 2015

At a glance

  • Drugs RXI 109 (Primary)
  • Indications Keloids
  • Focus Therapeutic Use
  • Sponsors RXi Pharmaceuticals
  • Most Recent Events

    • 25 Mar 2015 New trial record
    • 23 Mar 2015 According to RXi Pharmaceuticals media release, this trial is expected to begin in near future.
    • 15 Feb 2015 Trial design presented at the 73rd Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top